Alcresta is a leading medical nutrition company leveraging its proprietary platform to develop and commercialize a broad range of innovative, point-of-care, enzyme-based products designed to support proper nutrition.

Read more

Alcresta Presents New Data Demonstrating Potential of Proprietary Enzyme-Based Technology to Improve Nutrition in Patients with Exocrine Pancreatic Insufficiency

Read More >

Alcresta Appoints John H. Tucker to Chief Executive Officer

Read More >

Alcresta Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Develop Point-of-Care Nutritional Products

Read More >